FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

 OGD Suitability Tracking Report
(Sorted by Drug Name)
as of January 7, 2008

Drug/Strength Petition No./Firm Dosage Form Status Status Date
ABACAVIR SULFATE 60 MG

07P-0407/CP1
MATRIX LABORATORIES
TABLETS Pending 10/31/2007 
ACETAMINOPHEN 120 MG
CODEINE PHOSPHATE 12 MG
94P-0182/CP1
WE PHARMS
CHEWABLE TABLET Withdrawn 3/26/2007 
ACETAMINOPHEN 150 MG
ASPIRIN 180 MG
94P-0212/CP1
MIKART
TABLET Withdrawn 3/26/2007 
ACETAMINOPHEN 150 MG
ASPIRIN 180 MG
92P-0282/CP4
MIKART
CAPSULE OR TABLET Withdrawn 3/26/2007 
ACETAMINOPHEN 150 MG
ASPIRIN 180 MG
92P-0282/CP3
MIKART
CAPSULE OR TABLET Withdrawn 3/26/2007 
ACETAMINOPHEN 150 MG
ASPIRIN 180 MG
92P-0282/CP2
MIKART
CAPSULE OR TABLET Withdrawn 3/26/2007 
ACETAMINOPHEN 150 MG
ASPIRIN 180 MG
94P-0211/CP1
MIKART
TABLET Withdrawn 3/26/2007 
ACETAMINOPHEN 150 MG
ASPIRIN 180 MG
94P-0210/CP1
MIKART
TABLET Withdrawn 3/26/2007 
ACETAMINOPHEN 150 MG
ASPIRIN 180 MG
92P-0282/CP1
MIKART
CAPSULE OR TABLET Withdrawn 3/26/2007 
ACETAMINOPHEN 160 MG/5ML
CODEINE PHOSPHATE 6 MG/5 ML
87P-0323/CP
KLEINFELD, KAPLAN & BECKER
SYRUP Withdrawn 3/26/2007 
ACETAMINOPHEN 200MG;200MG; 200MG
HYDROCODONE BITARTRATE 5MG;7.5MG;10MG
02P-0004/CP1
SHOTWELL AND CARR, INC.
TABLET; ORAL Denied 3/17/2003 
ACETAMINOPHEN 300 MG
CODEINE PHOSPHATE 30 MG
85P-0543/CP
SOFTAN
SOFT GELATIN CAPSULE Withdrawn 3/26/2007 
ACETAMINOPHEN 300 MG
BUTALBITAL 50 MG
04P-0561/CP1
LACHMAN CONSULTANT SERVICES
CAPSULES Approved 3/31/2005 
ACETAMINOPHEN 300 MG
BUTALBITAL 50 MG
04P-0560/CP1
LACHMAN CONSULTANT SERVICES
CAPSULES Approved 3/31/2005 
ACETAMINOPHEN 325 MG
PROPOXYPHENE NAPSYLATE 100 MG
99P-2247/CP1
MIKART INC.
TABLET; ORAL, CAPSULE;ORAL Denied 3/2/2001 
ACETAMINOPHEN 325 MG
BUTALBITAL 50 MG
93P-0346/CP1
MIKART
CAPSULE OR TABLET Withdrawn 3/26/2007 
ACETAMINOPHEN 325 MG
ASPIRIN 325 MG
86P-0361/CP
BOCK PHARMA
TABLET Withdrawn 3/26/2007 
ACETAMINOPHEN 325 MG ; 325 MG
OXYCODONE HYDROCHLORIDE 4.5 MG ; 2.25 MG
98P-1219/CP1
KING AND SPALDING
TABLET; ORAL Denied 2/26/2001 
ACETAMINOPHEN 400 MG
BUTALBITAL 50 MG
07P-0030/CP1
LACHMAN CONSULTANT SERVICES
CAPSULES Pending 1/25/2007 
ACETAMINOPHEN 400 MG;400 MG:400MG
HYDROCODONE BITARTRATE 5MG;7.5 MG:10 MG
99P-4107/CP1
PHARMACEUTICAL ASSOCIATES, INC
LIQUID; ORAL Denied 3/2/2001 
ACETAMINOPHEN 50 MG
PROPOXYPHENE NAPSYLATE 500 MG
99P-4649/CP1
MIKART INC.
TABLET/CAPSULES; ORAL Denied 3/1/2001 
ACETAMINOPHEN 500 mg
OXYCODONE HYDROCHLORIDE 10 mg
99P-2798/CP1
KING AND SPALDING
TABLET; ORAL Approved 6/13/2000 
ACETAMINOPHEN 500 MG
BUTALBITAL 50 MG
99P-2149/CP1
MIKART INC.
TABLET; ORAL, CAPSULE;ORAL Denied 4/14/2000 
ACETAMINOPHEN 500 MG
OXYCODONE HYDROCHLORIDE 5 MG
85P-0543/CP3
SOFTAN
SOFT GELATIN CAPSULE Withdrawn 3/26/2007 
ACETAMINOPHEN 500 MG
CODEINE PHOSPHATE 7.5 OR 15 MG
85P-0543/CP2
SOFTAN
SOFT GELATIN CAPSULE Withdrawn 3/26/2007 
ACETAMINOPHEN 500 MG
PROPOXYPHENE HYDROCHLORIDE 32 MG
85P-0581/CP
SOFTAN
SOFT GELATIN CAPSULE Withdrawn 3/26/2007 
ACETAMINOPHEN 500 MG
CODEINE PHOSPHATE 30 MG OR 60 MG
84P-0228/CP1
MCNEIL
CAPSULE Withdrawn 3/26/2007 
ACETAMINOPHEN 500 MG
CODEINE PHOSPHATE 45 MG
93P-0314/CP1
MIKART
CAPSULE OR TABLET Withdrawn 3/26/2007 
ACETAMINOPHEN 500 MG/15 ML
OXYCODONE HYDROCHLORIDE 7.5 MG/15 ML
99P-2776/CP1
KING AND SPALDING
LIQUID; ORAL Denied 6/13/2000 
ACETAMINOPHEN 534.6 MG
CAFFEINE 45 MG
07P-0272/CP1
LACHMAN CONSULTANT SERVICES
TABLETS Pending 7/16/2007 
ACETAMINOPHEN 650 MG
BUTALBITAL 50 MG
07P-0194/CP1
LACHMAN CONSULTANT SERVICES
CAPSULES Pending 5/22/2007 
ACETAMINOPHEN 650 MG
BUTALBITAL 50 MG
99P-1657/CP1
MIKART INC.
TABLET; ORAL, CAPSULE;ORAL Approved 4/14/2000 
ACETAMINOPHEN 650 MG
CODEINE PHOSPHATE 15 MG
86P-0200/CP
MIKART
CAPSULE OR TABLET Withdrawn 3/26/2007 
ACETAMINOPHEN 750 MG
BUTALBITAL 50 MG
99P-2150/CP1
MIKART INC.
TABLET; ORAL, CAPSULE;ORAL Approved 4/14/2000 
ACETAMINOPHEN 770 MG, 385 MG
CAFFEINE 60 MG, 30 MG
03P-0505/CP1
LACHMAN CONSULTANT SERVICES
TABLET Withdrawn 10/19/2004 
ACETAMINOPHEN; 320 MG/10 ML
HYDROCODONE BITARTRATE 10 MG/10 ML
01P-0130/CP2
PHARMACEUTICAL ASSOCIATES, INC
SOLUTION; ORAL Denied 7/9/2002 
ACETAMINOPHEN; 325 MG & 500MG/15 ML
HYDROCODONE BITARTRATE 10 MG/15 ML
00P-1243/CP1
PHARMACEUTICAL ASSOCIATES, INC
SOLUTION; ORAL Denied 5/7/2001 
ACETAMINOPHEN; 325 MG/15 ML
HYDROCODONE BITARTRATE 7.5 MG/15 ML
01P-0214/CP1
PHARMACEUTICAL ASSOCIATES
SOLUTION; ORAL Approved 8/20/2001 
ACETAMINOPHEN; 325mg and 325 mg
OXYCODONE HYDROCHLORIDE 7.5 mg and 10 mg
00P-1270/CP1
KING AND SPALDING
TABLET; ORAL Approved 9/9/2000 
ACETAMINOPHEN; 325MG/10ML
HYDROCODONE BITARTRATE 10MG/10ML
00P-1291/CP1
PHARMACEUTICAL ASSOCIATES, INC
SOLUTION; ORAL Denied 5/7/2001 
ACETAMINOPHEN; 400mg per tab
OXYCODONE HYDROCHLORIDE 2.5mg;5mg;7.5mg;10mg
00P-1271/CP1
KING AND SPALDING
TABLET; ORAL Approved 9/9/2000 
ACETAMINOPHEN; 500 MG
PROPOXYPHENE NAPSYLATE 100 MG
00P-1324/CP1
MIKART
TABLETS AND/OR CAPSULES Denied 4/30/2001 
ACETAMINOPHEN; 500 MG
HYDROCODONE BITARTRATE 10 MG
01P-0251/CP1
MALLINKRODT
SOLUTION; ORAL Withdrawn 8/23/2001 
ACETAMINOPHEN; 500 MG/15 ML
HYDOCODONE BITARTRATE 10 MG/15 ML
01P-0144/CP1
PHARMACEUTICAL ASSOCIATES INC.
SOLUTION; ORAL Approved 8/20/2001 
ACETAMINOPHEN; 650 MG/ 30 ML
HYDROCODONE BITARTRATE 10 MG/30 ML
00P-1243/CP2
PHARMACEUTICAL ASSOCIATES INC.
SOLUTION; ORAL Denied 5/7/2001 
ACETAMINOPHEN; 650 MG/15 ML
HYDROCODONE BITARTRATE 10 MG/15 ML
01P-0130/CP1
PHARMACEUTICAL ASSOCIATES, INC
SOLUTION; ORAL Approved 8/20/2001 
ACETAMINOPHEN; 650MG/30 ML
HYDROCODONE BITARTRATE 10MG/30ML
00P-1431/CP1
PHARMACEUTICAL ASSOCIATES INC
SOLUTION; ORAL Withdrawn 9/6/2000 
ACYCLOVIR 200 MG

99P-5452/CP1
THE WEINBERG GROUP INC
TABLETS FOR ORAL SUSPENSION Approved 6/13/2000 
ACYCLOVIR 400MG & 800 MG

99P-5453/CP1
THE WEINBERG GROUP INC.
TABLET; FOR ORAL SUSPENSION Approved 6/13/2000 
ACYCLOVIR 5%

96P-0307/CP1
PITNEY, HARDIN, KIPP & SZUCH
CREAM; TOPICAL Withdrawn 3/26/2007 
ACYCLOVIR SODIUM 5 MG/ML

95P-0268/CP1
WILMER, CUTLER, PICKERING
READY TO USE INFUSION Withdrawn 3/26/2007 
ADENOSINE 18 MG/6 ML
30 MG/10 ML
04P-0326/CP1
APOTEX CORPORATION
INJECTION Denied 8/22/2007 
ALBUTEROL SULFATE .083% (base)

02P-0448/CP1
SENSORMEDICS CORPORATION
INHALATION SOLUTION Denied 12/17/2003 
ALBUTEROL SULFATE 0.0417%

00P-0913/CP1
MCDERMOTT, WILL AND EMERY
SOLUTION; INHALATION Approved 6/13/2000 
ALBUTEROL SULFATE 2 MG & 4 MG

97P-0387/CP1
RICHARD A. HAMER ASS., INC.
TABLET; SUBLINGUAL Withdrawn 3/26/2007 
ALBUTEROL SULFATE 2 MG, AND
4 MG
92P-0335/CP1
WE PHARMS
CHEWABLE TABLET Withdrawn 3/26/2007 
ALBUTEROL SULFATE 4 MG

91P-0348/CP1
HAMER
CAPSULE; ETENDED-RELEASE Withdrawn 3/26/2007 
ALCLOMETASONE DIPROPIONATE 0.05%

06P-0369/CP1
KIRKPATRICK & LOCKHART
LOTION; TOPICAL Pending 9/13/2006 
ALPRAZOLAM 0.25 MG

06P-0288/CP1
BECKLOFF ASSOCIATES
ORALLY DISINTEGRATING TABLETS Pending 8/1/2006 
AMINO ACID 15%

07P-0113/CP1
B BRAUN MEDICAL
INJECTION Pending 4/4/2007 
AMINO ACID 15 % 1 L GLASS BOTTLE

07P-0300/CP1
B. BRAUN MEDICAL
INJECTION Pending 8/8/2007 
AMINO ACIDS 10% 1000mL & 2000mL

00P-1470/CP1
BAXTER HEALTHCARE CORP
INJECTION Approved 1/11/2001 
AMIODARONE 100 MG

01P-0445/CP1
TARO
TABLET; ORAL Withdrawn 10/16/2001 
AMIODARONE 400 MG

99P-0343/CP1
OLSON FRANK AND WEEDA
TABLET; ORAL Approved 7/21/1999 
AMIODARONE HYDROCHLORIDE 100 MG

01P-0125/CP1
OLSON, FRANK AND WEEDA, P.C.
TABLET; ORAL Approved 8/2/2001 
AMIODARONE HYDROCHLORIDE 300 mg

02P-0394/CP1
TARO RESEARCH INSTITUTE
TABLETS Approved 3/6/2003 
AMIODARONE HYDROCHLORIDE 300mg/6mL, 450mg/9mL

02P-0484/CP1
LACHMAN CONSULTANT SERVICES
INJECTION Approved 2/25/2003 
AMIODARONE HYDROCHLORIDE 450 mg/9 mL

02P-0480/CP1
BIONICHE PHARMA GROUP
INJECTION Approved 2/25/2003 
AMIODARONE HYDROCHLORIDE 50 MG/ ML 9 ML VIALS

02P-0346/CP1
GENSIA SICOR
INJECTION Approved 2/25/2003 
AMIODARONE HYDROCHLORIDE 50mg/mL, 18mL vial

02P-0419/CP1
BIONICHE PHARMA GROUP
INJECTION Withdrawn 4/22/2003 
AMIODARONE HYDROCHLORIDE 900 MG/18 ML

00P-1352/CP1
GENSIA SICOR
INJECTION Approved 1/16/2001 
AMLODIPINE 5 MG & 10 MG

01P-0239/CP1
CIPHER PHARMACEUTICALS LTD.
CAPSULE; ORAL Withdrawn 2/12/2004 
AMLODIPINE BESYLATE 2.5 MG, 5 MG, 10 MG

05P-0066/CP1
DLA PIPER RUDNICK GRAY CARY
CAPSULES Denied 6/7/2006 
AMOXICILLIN 125MG,250MG,200MG
400MG,500MG,875MG
99P-5450/CP1
THE WEINBERG GROUP INC.
TABLETS FOR ORAL SUSPENSION Approved 6/13/2000 
AMOXICILLIN 200 MG, 400 MG
CLAVULANATE POTASSIUM 28.5 MG, 57 MG
04P-0157/CP1
THE WEINBERG GROUP
TABLETS FOR ORAL SUSPENSION Approved 9/28/2006 
AMOXICILLIN 300 mg, 600 mg

02P-0358/CP1
THE WEINBERG GROUP
TABLETS FOR ORAL SUSPENSION Approved 11/26/2002 
AMOXICILLIN 600mg
CLAVULANATE POTASSIUM 42.9mg
02P-0406/CP1
THE WEINBERG GROUP, INC.
TABLETS FOR ORAL SUSPENSION Denied 10/15/2004 
ASPIRIN 356.4MG
CAFFEINE 30 MG
86P-0359/CP
CENTRAL PHARMS
TABLET Withdrawn 3/26/2007 
ASPIRIN 650 MG
BUTALBITAL 50 MG
96P-0021/CP1
SAVAGE LABS
CAPSULES Withdrawn 3/26/2007 
ATORVASTATIN CALCIUM 10MG/20MG/40MG/80MG

04P-0418/CP1
LACHMAN CONSULTANT SERVICES
CAPSULES Withdrawn 7/1/2005 
AZATADINE MALEATE 1 MG
PHENYLPROPANOLAMINE HYDROCHLORIDE 75 MG
85P-0492/CP
SKF
EXTENDED-RELEASE CAPSULE Withdrawn 3/26/2007 
AZATADINE MALEATE 1 MG
PHENYLEPHRINE HYDROCHLORIDE 30 MG
95P-0351/CP1
BOCK PHARMACEUTICAL COMPANY
TABLET; ORAL Withdrawn 3/23/2000 
AZATHIOPRINE 75 MG & 100 MG

01P-0379/CP1
AAI INTERNATIONAL
TABLET; ORAL Approved 12/17/2001 
BACLOFEN 10 mg, 20 mg

02P-0078/CP1
KLEINFELD, KAPLAN & BECKER
ORALLY DISINTEGRATING TABLETS Suspended 2/3/2004 
BACLOFEN 10 MG/5 ML

05P-0156/CP1
PHASE V PHARMACEUTICALS
ORAL SOLUTION Withdrawn 7/18/2005 
BENZONATATE 150 MG

04P-0321/CP1
LACHMAN CONSULTANT SERVICES
CAPSULES Approved 11/23/2004 
BENZPHETAMINE HYDROCHLORIDE 25 MG, 50 MG

05P-0406/CP1
LACHMAN CONSULTANT SERVICES
CAPSULES Approved 6/27/2007 
BENZTROPINE MESYLATE 0.5 MG/5 ML

85P-0423/CP
RIM CONSULTING
SYRUP Withdrawn 3/26/2007 
BETAMETHASONE VALERATE 0.12%

06P-0438/CP1
OLSSON, FRANK AND WEEDA
NON-AEROSOL FOAM Pending 11/7/2006 
BISOPROLOL FUMARATE 5 MG, 10 MG, 20 MG
HYDROCHLOROTHIAZIDE 12.5 MG
07P-0071/CP1
LACHMAN CONSULTANT SERVICES
TABLETS Pending 3/15/2007 
BROMPHENIRAMINE MALEATE 12 MG
PSEUDOEPHEDRINE HYDROCHLORIDE 120 MG
83N-0095/CP
UAD LABS
EXTENDED-RELEASE CAPSULE Withdrawn 3/26/2007 
BUMETANIDE 6.25 MG/25 ML

05P-0006/CP1
BEN VENUE LABORATORIES
INJECTION Pending 1/18/2005 
BUTALBITAL 25 MG, 50 MG
ACETAMINOPHEN 300 MG, 600 MG
02P-0056/CP1
SHOTWELL & CARR, INC.
TABLET; ORAL Pending 2/28/2003 
BUTALBITAL 50 MG
ACETAMINOPHEN 325 MG
95P-0279/CP1
MIKART
CAPSULES AND TABLETS Withdrawn 3/26/2007 
BUTALBITAL 50 MG
ACETAMINOPHEN 500 MG
95P-0279/CP4
MIKART
CAPSULES AND TABLETS Withdrawn 3/26/2007 
BUTALBITAL 50 MG
ACETAMINOPHEN 325 MG
95P-0279/CP2
MIKART
CAPSULES AND TABLETS Withdrawn 3/26/2007 
BUTALBITAL 50 MG
ACETAMINOPHEN 500 MG
95P-0279/CP3
MIKART
CAPSULES AND TABLETS Withdrawn 3/26/2007 
BUTALBITAL 50 MG
ACETAMINOPHEN 300 MG
06P-0086/CP1
LACHMAN CONSULTANT SERVICES
TABLETS Approved 8/18/2006 
CALCITONIN, SALMON 2500 IU/0.25 MG

05P-0070/CP1
LATHAM & WATKINS
TABLET OR CAPSULE Denied 6/2/2006 
CALCITONIN-SALMON 100 IU/ML-1ML VIALS

00P-1213/CP1
FERRING PHARMACEUTICALS
INJECTION Approved 6/13/2000 
CAPTOPRIL 25 MG/5 ML

98P-0199/CP1
MIRAN CONSULTING, INC.
SOLUTION; ORAL Withdrawn 3/26/2007 
CAPTOPRIL 25 MG/ML

95P-0008/CP1
ROXANE LABS, INC.
ORAL SOLUTION Withdrawn 3/26/2007 
CARBAMAZEPINE 100mg, 300mg, 400mg

03P-0083/CP1
TARO PHARMACEUTICALS
TABLETS Approved 12/17/2003 
CARBAMAZEPINE 200 MG

01P-0028/CP1
TARO RESEARCH INSTITUTE LTD.
TABLET; CHEWABLE Approved 5/8/2001 
CARBAMAZEPINE 200 MG/5 ML

03P-0304/CP1
TARO PHARMACEUTICALS
ORAL SUSPENSION Pending  
CARBAMAZEPINE 200 MG/5 ML

89P-0399/CP
GUIDELINES
ORAL SUSPENSION Withdrawn 3/26/2007 
CARBIDOPA 25 MG; 10 MG; 25 MG
LEVODOPA 100MG; 100MG; 250MG
02P-0033/CP1
LACHMAN CONSULTANT SERVICES
TABLETS; ORALLY DISINTEGRATING Approved 9/25/2002 
CARBIDOPA/LEVODOPA 25/100 MG
25/250 MG
95P-0100/CP1
ATHENA NEUROSCIENCES, INC.
POWDER FOR ORAL SOLUTION Withdrawn 3/26/2007 
CARBIDOPA; 10MG & 25MG & 25MG
LEVODOPA 100MG & 100MG &250MG
01P-0358/CP1
THE WEINBERG GROUP, INC.
TABLET FOR ORAL SUSPENSION Approved 8/9/2002 
CARBINOXAMINE MALEATE 4 MG

04P-0451/CP1
NUTEC INCORPORATED
CHEWABLE TABLET Pending 10/8/2004 
CARBOPLATIN 1000 MG/100 ML
MULTIPLE DOSE VIAL
05P-0398/CP1
LACHMAN CONSULTANT SERVICES
INJECTION Pending 10/5/2005 
CARBOPLATIN 50 MG/5 ML ;10MG/ML
150 MG/15 ML;10MG/ML
01P-0036/CP1
VENABLE
INJECTION Approved 11/30/2001 
CARBOPLATIN 600 MG/60 ML

03P-0220/CP1
FAULDING
INJECTION Suspended 2/3/2004 
CARISOPRODOL 200 MG

01P-0526/CP1
ATLEY PHARMACEUTICALS, INC.
TABLET; ORAL Denied 7/3/2002 
CARISOPRODOL 200 MG
ACETAMINOPHEN 325 MG
03P-0460/CP1
ANABOLIC LABORATORIES, INC.
TABLET; ORAL Pending 2/4/2004 
CARISOPRODOL 350 mg

02P-0138/CP1
LACHMAN CONSULTANT SERVICES
ORALLY DISINTEGRATING TABLETS Withdrawn 7/25/2002 
CARVEDILOL PHOSPHATE 10, 20, 40, 80 MG

07P-0103/CP1
KELLER AND HECKMAN
TABLET; EXTENDED-RELEASE; ORAL Pending 4/2/2007 
CEFACLOR 125 MG, 187 MG
250 MG, 375 MG
99P-5447/CP1
THE WEINBERG GROUP INC.
TABLET; CHEWABLE;ORAL Approved 6/13/2000 
CEFACLOR 125 MG, 375 MG
375 MG, 500 MG
99P-5448/CP1
THE WEINBERG GROUP INC.
TABLETS FOR ORAL SUSPENSION Approved 6/13/2000 
CEFACLOR 500 MG

00P-1397/CP1
THE WEINBERG GROUP INC.
TABLET; CHEWABLE Approved 4/17/2001 
CEFADROXIL HEMIHYDRATE 125MG,250MG,500MG

99P-5449/CP1
THE WEINBERG GROUP INC.
TABLETS FOR ORAL SUSPENSION Approved 6/13/2000 
CEFAZOLIN 2 G VIALS

07P-0214/CP1
SANDOZ
INJECTION Pending 6/5/2007 
CEFAZOLIN SODIUM, STERILE 100 G & 300 G

99P-4870/CP1
QUINN CONSULTING SERVICES
FOR INJECTION Approved 4/12/2002 
CEFDINIR 187.5, 250, 300 MG

06P-0265/CP1
LUPIN PHARMACEUTICALS
CHEWABLE TABLETS Pending 7/5/2006 
CEFDITOREN PIVOXIL 400 MG

05P-0176/CP1
LACHMAN CONSULTANT SERVICES
TABLETS Approved 7/14/2005 
CEFIXIME 100 MG/ML

07P-0404/CP1
LUPIN PHARMACEUTICALS
ORAL SUSPENSION Pending 10/31/2007 
CEFIXIME 100MG, 150MG, 200MG

04P-0263/CP1
LUPIN PHARMACEUTICALS
CHEWABLE TABLETS Approved 10/6/2005 
CEFIXIME 200 MG/5 ML

05P-0013/CP1
LUPIN PHARMACEUTICALS
ORAL SUSPENSION Approved 4/8/2005 
CEFOXITIN 100 GRAM, 300 GRAM

03P-0227/CP1
SAMSON MEDICAL TECHNOLOGIES
INJECTION Approved 10/1/2003 
CEFPODOXIME PROXETIL 50 mg, 100 mg

02P-0444/CP1
THE WEINBERG GROUP
TABLETS FOR ORAL SUSPENSION Denied 6/7/2005 
CEFPROZIL 125 MG, 250 MG

04P-0173/CP1
LACHMAN CONSULTANT SERVICES
TABLETS FOR ORAL SUSPENSION Denied 6/7/2005 
CEFTAZIDIME 100GM PHARM BULK PKG

03P-0292/CP1
SAMSON MEDICAL TECHNOLOGIES
INJECTION Pending  
CEFTRIAXONE 100 GRAM

05P-0114/CP1
SAMSON MEDICAL TECHNOLOGIES
INJECTION Approved 7/14/2005 
CEFUROXIME AXETIL 125mg and 250mg

02P-0414/CP1
THE WEINBERG GROUP, INC
TABLETS FOR ORAL SUSPENSION Denied 4/29/2004 
CEFUROXIME SODIUM, STERILE 75 G & 225 G

99P-4871/CP1
QUINN CONSULTING SERVICES
FOR INJECTION Approved 4/12/2002 
CEPHALEXIN 125MG,250MG,500MG

99P-5451/CP1
THE WEINBERG GROUP INC
TABLETS FOR ORAL SUSPENSION Approved 6/13/2000 
CETIRIZINE HYDROCHLORIDE 5 MG, 10 MG

06P-0122/CP1
LACHMAN CONSULTANT SERVICES
ORALLY DISINTEGRATING TABLETS Pending 3/24/2006 
CETIRIZINE HYDROCHLORIDE 5 MG; 10 MG

06P-0207/CP1
STRIDES
CAPSULES, SOFT GELATIN Pending 6/12/2006 
CHLORHEXIDINE GLUCONATE 0.5%

88P-0036/CP
ARENT, FOX, ET. AL
SPRAY Withdrawn 3/26/2007 
CHLORHEXIDINE GLUCONATE 2%
ISOPROPYL ALCOHOL 70%
05P-0074/CP1
APLICARE INC.
TOPICAL SOLUTION Pending 4/8/2005 
CHLORHEXIDINE GLUCONATE 2%
ISOPROPOL ALCOHOL 70%
04P-0528/CP1
CARDINAL HEALTH
SOLUTION; TOPICAL Pending 12/6/2004 
CHLORHEXIDINE GLUCONATE 2% W/V
ISOPROPYL ALCOHOL 70% V/V
05P-0226/CP1
APLICARE
PREOPERATIVE SKIN PREP Pending 6/17/2005 
CHLORZOXAZONE 250 MG

90P-0084/CP1
MIKART
CAPSULE Withdrawn 3/26/2007 
CHLORZOXAZONE 375 MG

05P-0044/CP1
LACHMAN CONSULTANT SERVICES
TABLETS Approved 4/8/2005 
CHLORZOXAZONE 500 MG

82N-0032/CP6
MIKART
CAPSULE Withdrawn 3/26/2007 
CHOLESTYRAMINE 2 G

95P-0277/CP1
MAYRAND PHARMACEUTICALS, INC
TABLET; ORAL (CHEWABLE) Withdrawn 3/26/2007 
CHOLESTYRAMINE 4 GM

86P-0123/CP
PARKE DAVIS
CHEWABLE TABLET Withdrawn 3/26/2007 
CHOLESTYRAMINE 500 MG

86P-0474/CP
BRISTOL MYERS
CAPSULE Withdrawn 3/26/2007 
CHOLESTYRAMINE RESIN 4 G

87P-0301/CP
CIBA
GEL Approved 3/26/2007 
CIMETIDINE 200,300,400 OR 800MG

93P-0048/CP1
FLEMINGTON
EFFERVESCENT TABLET Withdrawn 3/26/2007 
CIPROFLOXACIN HYDROCHLORIDE 0.4 ML UNIT DOSE

04P-0222/CP1
STRADLING YOCCA CARLSON & RAUT
OPHTHALMIC SOLUTION Pending 5/24/2004 
CIPROFLOXACIN HYDROCHLORIDE 100 MG, 250 MG
500 MG, 750 MG
07P-0100/CP1
JRRAPOZA ASSOCIATES
CAPSULES Pending 4/4/2007 
CITALOPRAM HYDROBROMIDE 10 MG, 20 MG, 40 MG

03P-0551/CP1
FROMMER LAWRENCE & HAUG
CAPSULE Approved 3/29/2005 
CLADRIBINE 2 MG/ML - 5 ML VIAL

00P-1621/CP1
LIPOMED, INC.
INJECTION Denied 8/1/2001 
CLARITHROMYCIN 1000 MG

03P-0238/CP1
THE WEINBERG GROUP
EXTENDED-RELEASE TABLETS Approved 12/18/2003 
CLEMASTINE FUMARATE 1.34 MG
PSEUDOEPHEDRINE HYDROCHLORIDE 120 MG
87P-0314/CP
SANDOZ
CONTROLLED-RELEASE TABLET Withdrawn 3/26/2007 
CLEMASTINE FUMARATE 1.34 MG
PHENYLPROPANOLAMINE HYDROCHLORIDE 75 MG
88P-0350/CP
SCI CONSULTING
EXTENDED-RELEASE CAPSULE Withdrawn 3/26/2007 
CLINDAMYCIN PHOSPHATE 1%

07P-0124/CP1
OLSSON, FRANK AND WEEDA
FOAM; NON-AEROSOL Pending 4/4/2007 
CLOBETASOL PROPIONATE 0.05%
RLD = TEMOVATE
90P-0198/CP
KROSS
LOTION Withdrawn 3/26/2007 
CLOBETASOL PROPIONATE 0.05%

06P-0387/CP1
PADDOCK LABORATORIES
FOAM Pending 9/21/2006 
CLOBETASOL PROPIONATE 0.05%
RLD = TEMOVATE E
98P-0068/CP1
RICHARD HAMER ASSOCIATES, INC.
LOTION; TOPICAL Withdrawn 3/26/2007 
CLONAZEPAM 1 MG/5 ML

03P-0464/CP1
LACHMAN CONSULTANT SERVICES
ORAL SUSPENSION Approved 10/17/2005 
CLOZAPINE 12.5 MG

99P-1267/CP1
LACHMAN CONSULTANT SERVICES
TABLET;ORAL Approved 2/17/2000 
CLOZAPINE 200 MG

99P-1268/CP1
LACHMAN CONSULTANT SERVICES
TABLET; ORAL Approved 2/17/2000 
CLOZAPINE 50 mg

02P-0247/CP1
AAC CONSULTING GROUP
TABLETS Approved 11/26/2002 
CODEINE PHOSPHATE 10 MG/5 ML
DEXBROMPHENIRAMINE MALEATE 1 MG/5 ML
85P-0269/CP
BOCK PHARMA
SYRUP Withdrawn 3/26/2007 
COLISTIMETHATE SODIUM 150 MG/2 ML

05P-0050/CP1
PRG CONSULTING
SOLUTION Approved 10/17/2005 
CYCLOBENZAPRINE HYDROCHLORIDE 7.5 MG

03P-0461/CP1
ANABOLIC LABORATORIES
TABLET; ORAL Approved 10/15/2004 
CYCLOPHOSPHAMIDE 20 MG/ML, 250 ML PBP

88P-0379/CP
BAXTER
INJECTION Withdrawn 3/26/2007 
CYCLOPHOSPHAMIDE 20 MG/ML, 500 ML,PBP

88P-0011/CP
BAXTER
INJECTION Withdrawn 3/26/2007 
CYCLOSPORINE 25 MG; 50 MG; 100 MG

98P-0858/CP1
APOTEX CORP
TABLET; ORAL Approved 9/16/1999 
CYTARABINE 20 MG/ML, 12.5 ML

92P-0381/CP1
BRISTOL-MYERS SQUIBB
INJECTION Withdrawn 3/26/2007 
DEFEROXAMINE MESYLATE 1 GRAM

07P-0216/CP1
BEN VENUE LABORATORIES
INJECTION Pending 6/7/2007 
DEXAMETHASONE SODIUM PHOSPHATE 10 MG/ML
1 ML FILL SIZE
07P-0167/CP1
AKORN STRIDES
INJECTION Pending 5/9/2007 
DEXBROMPHENIRAMINE MALEATE 6 MG
PSEUDOEPHEDRINE SULFATE 120 MG
85P-0140/CP2
CENTRAL PHARMS
EXTENDED-RELEASE CAPSULE Withdrawn 3/26/2007 
DEXBROMPHENIRAMINE MALEATE 6 MG
PHENYLPROPANOLAMINE HYDROCHLORIDE 75 MG
85P-0238/CP2
BOCK PHARMA
EXTENDED-RELEASE CAPSULE Withdrawn 3/26/2007 
DEXBROMPHENIRAMINE MALEATE 6 MG
PSEUDOEPHEDRINE HYDROCHLORIDE 120 MG
85P-0140/CP
CENTRAL PHARMS
EXTENDED-RELEASE CAPSULE Withdrawn 3/26/2007 
DEXBROMPHENIRAMINE MALEATE 6 MG
PHENYLPROPANOLAMINE HYDROCHLORIDE 75 MG
87P-0265/CP
BOCK PHARMA
CONTROLLED-RELEASE TABLET Withdrawn 3/26/2007 
DEXTROAMPHETAMINE SULFATE 2.5 MG, 7.5 MG
15 MG, 20 MG, 30 MG
06P-0267/CP1
LACHMAN CONSULTANT SERVICES
TABLETS Approved 3/20/2007 
DEXTROAMPHETAMINE SULFATE 2.5 MG, 7.5 MG,
15 MG, 20 MG, 30 MG
05P-0418/CP1
LACHMAN CONSULTANT SERVICES
TABLETS Withdrawn 11/1/2005 
DIAZEPAM 2 MG/5 ML

85P-0499/CP
CAROLINA MEDCL
SYRUP Withdrawn 3/26/2007 
DICLOFENAC POTASSIUM 25 MG

03P-0298/CP1
THE WEINBERG GROUP
CAPSULES Pending 2/3/2004 
DICLOFENAC SODIUM 50 MG, 75 MG
MISOPROSTOL 200 MCG
07P-0428/CP1
KING & SPALDING LLP
CAPSULES Pending 11/5/2007 
DIFLUNISAL USP 375 MG

07P-0247/CP1
LACHMAN CONSULTANT SERVICES
TABLETS Pending 6/26/2007 
DIGOXIN 0.05 MG/ML

01P-0449/CP1
ROXANE LABORATORIES INC.
SOLUTION; ORAL Withdrawn 12/20/2001 
DIGOXIN 0.25 MG/5 ML

02P-0503/CP1
ROXANE LABORATORIES
ELIXIR Withdrawn  
DIHYDROERGOTAMINE MESYLATE 2 MG/ML

03P-0556/CP1
HYMAN, PHELPS & MCNAMARA
INJECTION Denied 4/1/2005 
DILTIAZEM HYDROCHLORIDE 120 MG 180 MG 240 MG
RLD=CARDIAZEM CD
96P-0510/CP1
LABOPHARM INC.
TABLETS;EXTENDED-RELEASE Withdrawn 3/26/2007 
DILTIAZEM HYDROCHLORIDE 120 MG 180 MG 240 MG
RLD = TIAZAC
97P-0195/CP1
LABOPHARM INC
TABLET; EXTENDED-RELEASE; ORAL Withdrawn 3/26/2007 
DILTIAZEM HYDROCHLORIDE 120 MG 180 MG 240 MG
RLD=DILACOR XR
97P-0192/CP1
LABOPHARM, INC.
TABLET; EXTENDED-RELEASE; ORAL Withdrawn 3/26/2007 
DILTIAZEM HYDROCHLORIDE 125MG/5ML;250MG/10ML

98P-0189/CP1
BEDFORD LABORATORIES
INJECTION Withdrawn  
DIPHENOXYLATE HYDROCHLORIDE 5 MG
ATROPINE SULFATE 0.05 MG
05P-0161/CP1
LACHMAN CONSULTANT SERVICES
TABLETS Pending 5/4/2005 
DIPHENOXYLATE HYDROCHLORIDE 5 MG
ATROPINE SULFATE 0.05 MG/5 ML
05P-0162/CP1
LACHMAN CONSULTANT SERVICES
ORAL SOLUTION Pending 5/4/2005 
DISOPYRAMIDE PHOSPHATE 200 MG OR 300 MG

84N-0116/CP
BIOCRAFT
EXTENDED-RELEASE TABLET Withdrawn 3/26/2007 
DISULFIRAM 500 MG/30 ML

85P-0215/CP
PADDOCK
ORAL SUSPENSION Withdrawn 3/26/2007 
DIVALPROEX SODIUM 1000 MG

03P-0178/CP1
LACHMAN CONSULTANT SERVICES
EXTENDED RELEASE TABLETS Approved 8/18/2003 
DIVALPROEX SODIUM 750 MG

04P-0195/CP1
LACHMAN CONSULTANT SERVICES
EXTENDED RELEASE TABLETS Approved 9/28/2004 
DONEPEZIL HYDROCHLORIDE 5 MG, 10 MG

07P-0226/CP1
LACHMAN CONSULTANT SERVICES
ORALLY DISSOLVING FILM STRIPS Pending 6/18/2007 
DOXYCYCLINE 150 MG

04P-0219/CP1
LACHMAN CONSULTANT SERVICES
CAPSULES Approved 9/28/2004 
DOXYCYCLINE 150 MG

01P-0516/CP1
LACHMAN CONSULTANT SERVICES
TABLET; ORAL Approved 4/12/2002 
DOXYCYCLINE 50 MG AND 100 MG

99P-4958/CP1
LACHMAN CONSULTANT SERVICES
TABLET; ORAL Approved 2/4/2000 
DOXYCYCLINE 75 MG

01P-0109/CP1
THE WEINBERG GROUP INC.
CAPSULE; ORAL Approved 8/2/2001 
DOXYCYCLINE 75 MG

01P-0515/CP1
LACHMAN CONSULTANT SERVICES
TABLET; ORAL Approved 4/12/2002 
DOXYCYCLINE (MONOHYDRATE) 125 MG

06P-0417/CP1
LACHMAN CONSULTANT SERVICES
TABLETS Pending 10/24/2006 
DOXYCYCLINE HYCLATE 75 MG, 100 MG

04P-0390/CP1
LACHMAN CONSULTANT SERVICES
TABLETS Pending 9/21/2004 
DOXYCYCLINE HYCLATE 75 MG, 100 MG

04P-0054/CP1
URL MUTUAL
CAPSULES Withdrawn 4/12/2004 
ECONAZOLE NITRATE 1%

98P-0745/CP1
MIRAN CONSULTING, INC.
OINTMENT; TOPICAL Withdrawn 3/26/2007 
EDETATE DISODIUM

05P-0085/CP1
MCGUFF PHARMACEUTICALS
INJECTION Pending 2/23/2005 
EFAVIRENZ 50 MG/100 MG/200 MG

05P-0407/CP1
LACHMAN CONSULTANT SERVICES
TABLETS FOR ORAL SUSPENSION Pending 10/12/2005 
EPIRUBICIN HYDROCHLORIDE 10mg/ 5mL;150mg/75mL

03P-0110/CP1
FAULDING PHARMACEUTICAL CO.
INJECTION Approved 8/13/2003 
EPIRUBICIN HYDROCHLORIDE 2 MG/ML
10 MG/5 ML
06P-0131/CP1
AAC CONSULTING
INJECTION Pending 4/11/2006 
ESCITALOPRAM OXALATE 10 MG, 20 MG

04P-0247/CP1
FROMMER LAWRENCE & HAUG
CAPSULE Approved 3/29/2005 
ESCITALOPRAM OXALATE 5 MG, 10 MG, 20 MG

07P-0239/CP1
LACHMAN CONSULTANT SERVICES
ORALLY DISSOLVING FILM STRIPS Pending 6/21/2007 
ESMOLOL HYDROCHLORIDE 2500 MG/VIAL

04P-0085/CP1
BEDFORD LABORATORIES
INJECTION Denied 6/7/2005 
ESTROPIPATE 1.2 mg

02P-0141/CP1
WOMEN FIRST HEALTHCARE
TABLETS Approved 9/24/2002 
ETHINYL ESTRADIOL 0.035 MG
NORETHINDRONE 0.4 MG
99P-1150/CP1
KIRKLAND & ELLIS
TABLET; CHEWABLE Approved 4/14/2000 
FAMOTIDINE 10 MG

04P-0353/CP1
LACHMAN CONSULTANT SERVICES
ORALLY DISSOLVING STRIPS Approved 7/5/2005 
FAMOTIDINE 10 MG

97P-0404/CP1
THOMAS BLAKE, R.PH
TABLET; ORAL; EFFERVESCENT Withdrawn 3/26/2007 
FAMOTIDINE 10MG

00P-1422/CP1
YAMANOUCHI PHARMA TECHNOLOGIES
TABLET; ORALLY DISINTEGRATING Approved 4/17/2001 
FENOFIBRATE 107 mg

02P-0148/CP1
LAVENDER CONSULTING SERVICES
TABLETS Approved 9/25/2002 
FENOPROFEN CALCIUM 400 MG

07P-0293/CP1
EMCURE PHARMACEUTICALS
CAPSULES Pending 7/26/2007 
FENTANYL 12.5 mcg/hr

02P-0478/CP1
LACHMAN CONSULTANT SERVICES
TRANSDERMAL SYSTEM Withdrawn 10/14/2003 
FENTANYL 37.5 mcg/hr
62.5 mcg/hr
04P-0069/CP1
LACHMAN CONSULTANT SERVICES
TRANSDERMAL SYSTEM Approved 7/7/2004 
FENTANYL CITRATE 1000 MCG, 1400 MCG

07P-0022/CP1
LACHMAN CONSULTANT SERVICES
ORAL TRANSMUCOSAL Pending 1/19/2007 
FEXOFENADINE HYDROCHLORIDE 30 MG/5 ML
60 MG/5 ML
06P-0397/CP1
LUPIN PHARMACEUTICALS
ORAL SUSPENSION Pending 10/6/2006 
FLOXURIDINE 500 MG/5 ML

86P-0242/CP
QUAD
INJECTION Withdrawn 3/26/2007 
FLUCONAZOLE 100 MG/50 ML

04P-0434/CP1
BEN VENUE LABORATORIES
INJECTION Approved 8/18/2006 
FLUDARABINE PHOSPHATE 25 mg/mL

02P-0245/CP1
GENSIA SICOR PHARMACEUTICALS
SOLUTION FOR INJECTION Approved 4/27/2004 
FLUDEOXYGLUCOSE F18 0.9-475 MCI/ML

07P-0126/CP1
PFI LLC
INJECTION Pending 4/9/2007 
FLUOCINOLONE ACETONIDE 0.01%
HYDROQUINONE 4%
03P-0279/CP1
JERUSSI CONSULTING
TOPICAL SOLUTION Denied 4/1/2005 
FLUOCINONIDE 0.05%

87P-0004/CP
HAMER
LOTION Denied 3/26/2007 
FLUOROURACIL 2.5%

01P-0288/CP1
Ferndale Laboratories Inc.
SOLUTION; TOPICAL Approved 1/8/2002 
FLUOROURACIL 5%

94P-0263/CP1
BRADLEY PHARMS
TOPICAL GEL Withdrawn 3/26/2007 
FLUOXETINE 20 MG & 40 MG

01P-0243/CP1
CIPHER PHARMACEUTICALS LTD.
CAPSULE; ORAL Withdrawn 7/31/2001 
FLUOXETINE 40 MG

00P-1365/CP1
LACHMAN CONSULTANT SERVICES
TABLET; ORAL Approved 1/12/2001 
FLURAZEPAM HYDROCHLORIDE 15 MG/5ML

85P-0091/CP
ROXANE
ORAL SOLUTION Withdrawn 3/26/2007 
FLURAZEPAM HYDROCHLORIDE 30 MG/ML

85P-0081/CP
ROXANE
ORAL SOLTUION Withdrawn 3/26/2007 
GABAPENTIN 100MG,300MG,400MG

00P-1419/CP1
LACHMAN CONSULTANT SERVICES
TABLET; ORAL Approved 1/12/2001 
GANCICLOVIR SODIUM 500 MG/10 ML

01P-0440/CP1
BEN VENUE LAOBRATORIES, INC.
INJECTION Suspended 2/3/2004 
GEMCITABINE 2 GM/VIAL

06P-0145/CP1
LACHMAN CONSULTANT SERVICES
INJECTION Approved 8/22/2007 
GLIMEPIRIDE 3 MG, 6 MG

04P-0123/CP1
LACHMAN CONSULTANT SERVICES
TABLETS Approved 7/7/2004 
GLIMEPIRIDE 8 MG

03P-0283/CP1
LACHMAN CONSULTANT SERVICES
TABLETS Approved 10/6/2003 
GLIPIZIDE 2.5 MG, 5 MG
METFORMIN HYDROCHLORIDE 250 MG, 500 MG
04P-0208/CP1
THE WEINBERG GROUP
TABLETS FOR ORAL SUSPENSION Approved 11/23/2004 
GLIPIZIDE 2.5 MG, 5 MG
METFORMIN HYDROCHLORIDE 250 MG, 500 MG
03P-0218/CP1
THE WEINBERG GROUP
TABLETS FOR ORAL SOLUTION Approved 7/30/2004 
GLIPIZIDE 2.5 mg, 5 mg
METFORMIN HYDROCHLORIDE 250mg/5mL;500mg/10mL
04P-0168/CP1
LACHMAN CONSULTANT SERVICES
ORAL SOLUTION Approved 11/23/2004 
GLYBURIDE 1.25 MG, 2.5 MG, 5MG
METFORMIN HYDROCHLORIDE 250 MG, 500 MG
04P-0209/CP1
THE WEINBERG GROUP
TABLETS FOR ORAL SUSPENSION Approved 11/23/2004 
GLYBURIDE 1.25MG, 2.5MG, 5 MG
METFORMIN HYDROCHLORIDE 250MG, 500MG,
03P-0534/CP1
LACHMAN CONSULTANT SERVICES
ORAL SOLUTION Approved 7/30/2004 
GLYBURIDE 1.25mg, 2.5mg, 5mg
METFORMIN HYDROCHLORIDE 250mg, 500mg, 500mg
03P-0188/CP1
THE WEINBERG GROUP
TABLETS FOR ORAL SOLUTION Approved 7/30/2004 
GLYCOPYRROLATE 1.5 MG

06P-0300/CP1
LACHMAN CONSULTANT SERVICES
TABLETS Approved 3/20/2007 
HOMATROPINE METHYLBROMIDE 1.5 MG
HYDROCODONE BITARTRATE 5 MG
88P-0061/CP
KLEINFELD, KAPLAN & BECKER
SOFT GELATIN CAPSULE Withdrawn 3/26/2007 
HYDRALAZINE HYDROCHLORIDE 25 MG/5ML

85P-0074/CP
ROXANE
ORAL SOLUTION Withdrawn 3/26/2007 
HYDROCHLOROTHIAZIDE 12.5 MG

05P-0060/CP1
LACHMAN CONSULTANT SERVICES
TABLETS Approved 4/8/2005 
HYDROCHLOROTHIAZIDE 50 MG
TRIAMTERENE 75 MG
86P-0427/CP
PAR
CAPSULE Withdrawn 3/26/2007 
HYDROCODONE BITARTRATE 10 MG
IBUPROFEN 200 MG
01P-0442/CP1
LACHMAN CONSULTANT SERVICES
TABLET; ORAL Approved 12/20/2001 
HYDROCODONE BITARTRATE 10 MG
ACETAMINOPHEN 300 MG
01P-0441/CP1
LACHMAN CONSULTANT SERVICES
TABLET; ORAL Approved 12/20/2001 
HYDROCODONE BITARTRATE 10 MG, 7.5 MG
ACETAMINOPHEN 400 MG, 400 MG
01P-0504/CP1
SHOTWELL & CARR, INC.
TABLET; ORAL Withdrawn 1/2/2002 
HYDROCODONE BITARTRATE 10 MG/15 ML
ACETAMINOPHEN 300 MG/15 ML
01P-0524/CP1
LACHMAN CONSULTANT SERVICES
SOLUTION; ORAL Approved 8/6/2002 
HYDROCODONE BITARTRATE 2.5 MG
IBUPROFEN 200 MG
05P-0180/CP1
LACHMAN CONSULTANT SERVICES
TABLETS Approved 7/14/2005 
HYDROCODONE BITARTRATE 2.5 MG
HOMATROPINE METHYLBROMIDE 0.75 MG
07P-0134/CP1
LACHMAN CONSULTANT SERVICES
TABLETS Pending 4/12/2007 
HYDROCODONE BITARTRATE 2.5 MG PER 5 ML
HOMATROPINE METHYLBROMIDE 0.75 MG PER 5 ML
07P-0119/CP1
LACHMAN CONSULTANT SERVICES
SYRUP Pending 4/5/2007